Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC18H17N3O |
InChIKeyRIGZCVNCFXYBEG-UHFFFAOYSA-N |
CAS Registry326823-27-2 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | IT | 17 Jun 2004 |